EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access

Profiles of Willingness to Use Pre-Exposure Prophylaxis Modalities and an HIV Vaccine Among Sexual and Gender Minority Individuals in Brazil, Mexico, and Peru: Cross-Sectional Online Survey

Jazmin Qquellon iD, Kelika A Konda iD, Oliver Elorreaga iD, Hamid Vega-Ramirez iD, Centli Guillén-Díaz-Barriga iD, Dulce Díaz-Sosa iD, Brenda Hoagland iD, Juan V Guanira iD, Marcos Benedetti iD, Cristina Pimenta iD, Beatriz Grinsztejn iD, Carlos F Caceres iD und 2 weitere

JMIR Public Health and Surveillance · 2026

DOI: 10.2196/75753 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift JMIR Public Health and Surveillance, 2026. Verfasst von Jazmin Qquellon und 13 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Investigación Interdisciplinaria en Sexualidad, Sida y Sociedad, Universidad Peruana Cayetano Heredia, Lima, Peru. Hauptthemen laut MEDLINE: Pre-Exposure Prophylaxis, HIV Infections, Sexual and Gender Minorities, AIDS Vaccines. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

HIV incidence continues to disproportionately affect sexual and gender minority (SGM) individuals in Latin America. Pre-exposure prophylaxis (PrEP), including long-acting products, urgently need scaling up in the region. Understanding PrEP modality preferences can help design effective implementation.

Objective

This study examined willingness to use different PrEP modalities and an HIV vaccine among SGM individuals aged 18 years or older from Brazil, Mexico, and Peru and factors associated with willingness to use 4 PrEP modalities.

Methods

We conducted a cross-sectional online survey in 2021; participants were recruited via apps (Grindr and Hornet) and social media (Facebook, Instagram, and WhatsApp). We used multivariate Poisson regression with robust variance (α=.05) to estimate prevalence ratios, identifying differences in willingness to use daily oral, event-driven oral, monthly oral, and bimonthly injectable PrEP. Models were constructed for each PrEP modality and adjusted for age, country, race, education, income, HIV risk score, HIV testing, and HIV risk perception. Variables were retained in the final adjusted models regardless of statistical significance.

Results

Among 16,951 respondents, 10,385 (61.3%) were Brazilian, 4996 (29.5%) Mexican, and 1570 (9.3%) Peruvian. Median age was 32 (IQR 26-39) years. Among the total respondents, 12,621 (74.4%) were willing to use monthly oral PrEP; 11,153 (65.8%) daily oral PrEP; 10,212 (60.2%) bimonthly injectable PrEP; and 14,044 (82.8%) an HIV vaccine. Only 6442 (38%) were willing to use event-driven oral PrEP. In Brazil, 6082 (66.8%) were willing to use daily oral, 3162 (36.1%) event-driven, 7640 (74.9%) monthly oral, and 6450 (63.3%) injectable PrEP; in Mexico, 3242 (67.8%) daily oral, 1958 (41%) event-driven, 3728 (76.5%) monthly oral, and 2805 (57.5%) injectable PrEP; in Peru, 799 (53.1%) daily oral, 584 (39.9%) event-driven, 830 (62.5%) monthly oral, and 610 (45.9%) injectable PrEP. In multivariable models, willingness to use each of the 4 PrEP modalities was positively associated with high self-perceived HIV risk (adjusted prevalence ratios [aPRs] 1.10-1.25) and higher HIV Incidence Risk Index scores (aPRs 1.08-1.22). Having lower education was associated with lower willingness for monthly oral and bimonthly injectable PrEP (aPR=0.93, 95% CI 0.89-0.97 and aPR=0.94, 95% CI 0.90-0.99, respectively). Never having been tested for HIV and testing more than 6 months ago were associated with lower willingness for daily oral PrEP (aPR=0.89, 95% CI 0.83-0.95 and aPR=0.95, 95% CI 0.91-0.99, respectively) and bimonthly injectable PrEP (aPR=0.80, 95% CI 0.74-0.86 and aPR=0.90, 95% CI 0.86-0.94, respectively).

Conclusions

Our results suggest a strong preference for long-acting formulations, including monthly oral and bimonthly injectable, among SGM individuals in Latin America. Further research is needed to address gaps in the understanding of prevention modalities. As additional PrEP modalities are included in HIV prevention programs, the development of accessible tools and community-based strategies will be essential to support informed PrEP choices and ensure equitable implementation across the region.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-Exposure ProphylaxisHIV InfectionsSexual and Gender MinoritiesAIDS VaccinesPatient Acceptance of Health CareHumansCross-Sectional StudiesFemaleAdultMaleBrazilMexicoPeruSurveys and QuestionnairesAdolescentMiddle AgedYoung Adult

Stichwörter der Autor:innen

HIV preventioncabotegravirlenacapavirmen who have sex with mentransgender womenvaccine

Substanzen

AIDS Vaccines

Autor:innen und Institutionen

  • Centro de Investigación Interdisciplinaria en Sexualidad, Sida y Sociedad, Universidad Peruana Cayetano Heredia, Lima, Peru.
  • Division Disease Prevention, Policy and Global Health, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, California, CA, United States.
  • Division of Epidemiology and Psychosocial Research, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Mexico City, Mexico.
  • Faculty of Psychology, National Autonomous University of Mexico, Mexico City, Mexico.
  • Department of Health Sciences, Metropolitan Autonomous University-Lerma (UAM-L), Lerma de Villada, Mexico.
  • Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.

ORCID-Profile: Jazmin Qquellon, Kelika A Konda, Oliver Elorreaga, Hamid Vega-Ramirez, Centli Guillén-Díaz-Barriga, Dulce Díaz-Sosa, Brenda Hoagland, Juan V Guanira, Marcos Benedetti, Cristina Pimenta, Beatriz Grinsztejn, Carlos F Caceres, Valdilea G Veloso, Thiago S Torres

Zitieren

APA

Qquellon, J., Konda, K. A., Elorreaga, O., Vega-Ramirez, H., Guillén-Díaz-Barriga, C., Díaz-Sosa, D., Hoagland, B., Guanira, J. V., Benedetti, M., Pimenta, C., Grinsztejn, B., Caceres, C. F., Veloso, V. G., & Torres, T. S. (2026). Profiles of Willingness to Use Pre-Exposure Prophylaxis Modalities and an HIV Vaccine Among Sexual and Gender Minority Individuals in Brazil, Mexico, and Peru: Cross-Sectional Online Survey. JMIR Public Health and Surveillance. https://doi.org/10.2196/75753

Vancouver

Qquellon J, Konda KA, Elorreaga O, Vega-Ramirez H, Guillén-Díaz-Barriga C, Díaz-Sosa D, et al. Profiles of Willingness to Use Pre-Exposure Prophylaxis Modalities and an HIV Vaccine Among Sexual and Gender Minority Individuals in Brazil, Mexico, and Peru: Cross-Sectional Online Survey. JMIR Public Health and Surveillance. 2026. doi:10.2196/75753

BibTeX
@article{Qquellon2026,
  author = {Qquellon, Jazmin and Konda, Kelika A and Elorreaga, Oliver and Vega-Ramirez, Hamid and Guillén-Díaz-Barriga, Centli and Díaz-Sosa, Dulce and Hoagland, Brenda and Guanira, Juan V and Benedetti, Marcos and Pimenta, Cristina and Grinsztejn, Beatriz and Caceres, Carlos F and Veloso, Valdilea G and Torres, Thiago S},
  title = {Profiles of Willingness to Use Pre-Exposure Prophylaxis Modalities and an HIV Vaccine Among Sexual and Gender Minority Individuals in Brazil, Mexico, and Peru: Cross-Sectional Online Survey},
  journal = {JMIR Public Health and Surveillance},
  year = {2026},
  doi = {10.2196/75753}
}
Kostenlos starten →